Search

Author/Creator Preston, Cathryn

1. Implications for sequencing of biologic therapy and choice of second anti‐TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti‐TNF therapy (IMSAT) therapeutic drug monitoring study. Issue 8 (29th August 2022)

Authors:
Chanchlani, Neil; Lin, Simeng; Auth, Marcus K.; Lee, Chai Leng; Robbins, Helena; Looi, Shi; Murugesan, Senthil V.; Riley, Tom; Preston, Cathryn; Stephenson, Sophie; Cardozo, Wendy; Sonwalkar, Sunil A.; Allah‐Ditta, Mohammed; Mansfield, Lynne; Durai, Dharmaraj; Baker, Mark; London, Ian; London, Em...
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 56:Issue 8(2022)
Page Start:
1250
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study. (May 2019)

Authors:
Patel, Vinod; Mazhar, Zia; Saich, Rebecca; Colleypriest, Ben; Tham, Tony C; Iqbal, Tariq H; Kaushik, Vishal; Murugesan, Senthil; Singh, Salil; Weaver, Sean; Preston, Cathryn; Butt, Assad; Smith, Melissa; Basude, Dharamveer; Beale, Amanda; Langlands, Sarah; Direkze, Natalie; Parkes, Miles; Torrent...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 4:Number 5(2019)
Page Start:
341
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗